You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

C1 inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Teenagers and Non-histaminergic Angioedema With Normal C1

Not yet recruiting
  • Hereditary Angioedema (HAE)
  • Angioedema
  • No Intervention
  • (no location specified)
Jan 5, 2023

Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium

Recruiting
  • Hereditary Angioedema
  • +11 more
  • PHA-022121 low dose
  • +3 more
  • Birmingham, Alabama
  • +7 more
Dec 5, 2022

Genetic Variants in Hereditary Angioedema

Not yet recruiting
  • Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
    • Barcelona, Spain
    • +1 more
    Apr 17, 2023

    Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • (no location specified)
    Oct 31, 2023

    Angioedema Trial in United States (Lanadelumab)

    Recruiting
    • Angioedema
    • Birmingham, Alabama
    • +7 more
    Mar 30, 2022

    Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

    Not yet recruiting
    • Advanced Solid Tumor
    • Non-small Cell Lung Cancers
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 15, 2023

    Hereditary Angioedema (HAE) Trial in Worldwide (Lanadelumab)

    Available
    • Hereditary Angioedema (HAE)
    • Angioedema
    • Lanadelumab 150 mg
    • Lanadelumab 300 mg
    • Scottsdale, Arizona
    • +19 more
    Sep 16, 2022

    Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)

    Recruiting
    • Hereditary Angioedema
    • +9 more
    • Birmingham, Alabama
    • +21 more
    Aug 11, 2022

    Traumatic Brain Injury, Trauma, Head Trial in Den Haag, Leiden, Rotterdam (C1 Inhibitor, Human, Placebo)

    Recruiting
    • Traumatic Brain Injury
    • Trauma, Head
    • C1 Inhibitor, Human
    • Placebo
    • Den Haag, Netherlands
    • +2 more
    Sep 6, 2021

    Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)

    Not yet recruiting
    • Locally Advanced Colon Cancer
    • (no location specified)
    Feb 16, 2023

    Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Birmingham, Alabama
    • +2 more
    Jan 3, 2023

    Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)

    Active, not recruiting
    • Hereditary Angioedema
    • +9 more
    • Birmingham, Alabama
    • +35 more
    Aug 23, 2022

    Healthy Adults Trial in Dallas (Treatment A, Treatment B)

    Not yet recruiting
    • Healthy Adults
    • Treatment A
    • Treatment B
    • Dallas, Texas
      Labcorp Clinical Research Unit Inc
    May 11, 2023

    End Stage Renal Disease, Chronic Kidney Diseases Trial in Los Angeles (Berinert, Placebo)

    Active, not recruiting
    • End Stage Renal Disease
    • Chronic Kidney Diseases
    • Los Angeles, California
      Cedars Sinai Medical Center
    Jan 5, 2022

    Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)

    Completed
    • Relapsed or Refractory Lymphoma
    • Itraconazole 200 mg
    • +3 more
    • Miami, Florida
      QPS- Miami
    Jan 12, 2023

    Bronchiectasis Adult Trial in Dundee (Alpha 1-Proteinase Inhibitor 180mg/kg, Alpha 1-Proteinase Inhibitor 120mg/kg, Sodium

    Not yet recruiting
    • Bronchiectasis Adult
    • Alpha 1-Proteinase Inhibitor 180mg/kg
    • +2 more
    • Dundee, United Kingdom
      NHS Tayside
    Oct 12, 2022

    Solid Tumor, Adult, Metastatic Solid Tumor, Metastatic NSCLC Trial in Adelaide (BBP-398, sotorasib)

    Recruiting
    • Solid Tumor, Adult
    • +3 more
    • Adelaide, South Australia, Australia
      Cancer Research SA
    Aug 15, 2022

    Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)

    Recruiting
    • Antipsychotic Induced Weight Gain
    • Non-alcoholic Steatohepatitis (NASH)
    • Miami, Florida
      Site 01
    Feb 3, 2023

    Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

    Not yet recruiting
    • Advanced Fallopian Tube Carcinoma
    • +10 more
    • Wee1 Inhibitor ZN-c3
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 25, 2023

    Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

    Not yet recruiting
    • Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Aug 23, 2023

    Covid19 Trial in Le Chesnay (C1 Inhibitor Human, Icatibant Injection, Placebo)

    Completed
    • Covid19
    • C1 Inhibitor Human
    • +2 more
    • Le Chesnay, France
      Hôpital Privé de Parly II
    Aug 17, 2021

    Angioedema Trial in Worldwide (Lanadelumab, Placebo)

    Completed
    • Angioedema
    • Birmingham, Alabama
    • +44 more
    Oct 24, 2022

    Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

    Not yet recruiting
    • Acute Myeloid Leukemia With KMT2A Rearrangement
    • Acute Myeloid Leukemia With NPM1 Mutation
    • Biospecimen Collection
    • +7 more
    • (no location specified)
    Jun 1, 2023

    Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))

    Recruiting
    • Alpha1-Antitrypsin Deficiency
    • Alpha-1 15%
    • Liquid Alpha1-Proteinase Inhibitor (Human)
    • Gainesville, Florida
    • +5 more
    Jan 13, 2023

    Acute Ischemic Stroke, Acute Renal Injury Trial in Basel (Conestat alfa (Ruconest®), NaCl 0.9%))

    Recruiting
    • Acute Ischemic Stroke
    • Acute Renal Injury
    • Conestat alfa (Ruconest®)
    • NaCl 0.9%)
    • Basel, Switzerland
      University Hospital Basel, Division of Internal Medicine
    Mar 16, 2022